{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:20:34Z","timestamp":1790828434173,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pt.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T12:30:55Z","timestamp":1605097855000},"page":"48-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":194,"title":["Ivermectin: An Anthelmintic, an Insecticide, and Much More"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2422-1847","authenticated-orcid":false,"given":"Richard J.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2020.10.005_bb0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The pharmacokinetics and interactions of ivermectin in humans \u2013 A mini-review","volume":"10","author":"Canga","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.pt.2020.10.005_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tvjl.2007.07.011","article-title":"The pharmacokinetics and metabolism of ivermectin in domestic animal species","volume":"179","author":"Gonz\u00e1lez Canga","year":"2009","journal-title":"Vet. J."},{"key":"10.1016\/j.pt.2020.10.005_bb0015","series-title":"Stomectol safety data sheet","first-page":"7","author":"Merck","year":"2019"},{"key":"10.1016\/j.pt.2020.10.005_bb0020","first-page":"563","article-title":"Ivermectin toxicity in small animals","volume":"28","author":"Bauck","year":"1987","journal-title":"Can. Vet. J."},{"key":"10.1016\/j.pt.2020.10.005_bb0025","series-title":"Ivermectin and Abamectin","year":"1989"},{"key":"10.1016\/j.pt.2020.10.005_bb0030","series-title":"Macrocyclic Lactontes in Antiparasitic Therapy","year":"2002"},{"key":"10.1016\/j.pt.2020.10.005_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpddr.2014.01.002","article-title":"High level expression of a glutamate-gated chloride channel gene in reproductive tissues of Brugia malayi may explain the sterilizing effect of ivermectin on filarial worms","volume":"4","author":"Li","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.pt.2020.10.005_bb0040","article-title":"The effects of ivermectin on Brugia malayi females in vitro: a transcriptomic approach","volume":"10","author":"Ballesteros","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2020.10.005_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/371707a0","article-title":"Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans","volume":"371","author":"Cully","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.10.005_bb0050","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1017\/S0031182000077970","article-title":"Molecular biology and electrophysiology of glutamate-gated chloride channels of invertebrates","volume":"113","author":"Cully","year":"1996","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2020.10.005_bb0055","doi-asserted-by":"crossref","first-page":"33167","DOI":"10.1074\/jbc.272.52.33167","article-title":"Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization","volume":"272","author":"Vassilatis","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2020.10.005_bb0060","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1093\/emboj\/16.19.5867","article-title":"avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans","volume":"16","author":"Dent","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.pt.2020.10.005_bb0065","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1073\/pnas.97.6.2674","article-title":"The genetics of ivermectin resistance in Caenorhabditis elegans","volume":"97","author":"Dent","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.10.005_bb0070","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0703937","article-title":"GLC-3: a novel fipronil and BIDN-sensitive, but picrotoxinin-insensitive, L-glutamate-gated chloride channel subunit from Caenorhabditis elegans","volume":"132","author":"Horoszok","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0075","doi-asserted-by":"crossref","first-page":"e22390","DOI":"10.1371\/journal.pone.0022390","article-title":"Glutamate-gated chloride channels of Haemonchus contortus restore drug sensitivity to ivermectin resistant Caenorhabditis elegans","volume":"6","author":"Glendinning","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.10.005_bb0080","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0020-7519(95)00036-2","article-title":"In vitro studies on the relative sensitivity to ivermectin of Necator americanus and Ancylostoma ceylanicum","volume":"25","author":"Richards","year":"1995","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0085","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0020-7519(93)90061-3","article-title":"Sensitivity to ivermectin and pyrantel of Ancylostoma ceylanicum and Necator americanus","volume":"23","author":"Behnke","year":"1993","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1471-4159.1999.0720066.x","article-title":"Diversification of Drosophila chloride channel gene by multiple posttranscriptional mRNA modifications","volume":"72","author":"Semenov","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pt.2020.10.005_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/hdy.2009.97","article-title":"The cys-loop ligand-gated ion channel gene superfamily of the parasitoid wasp, Nasonia vitripennis","volume":"104","author":"Jones","year":"2010","journal-title":"Heredity (Edinb)"},{"key":"10.1016\/j.pt.2020.10.005_bb0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2164-8-327","article-title":"The cys-loop ligand-gated ion channel gene superfamily of the red flour beetle, Tribolium castaneum","volume":"8","author":"Jones","year":"2007","journal-title":"BMC Genom."},{"key":"10.1016\/j.pt.2020.10.005_bb0105","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1086\/342102","article-title":"Scabies and pediculosis pubis: an update of treatment regimens and general review","volume":"35","author":"Wendel","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2020.10.005_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actatropica.2010.06.001","article-title":"The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors","volume":"116","author":"Kobylinski","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2020.10.005_bb0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijantimicag.2019.05.003","article-title":"Ivermectin: From theory to clinical application","volume":"54","author":"Ashour","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.pt.2020.10.005_bb0120","doi-asserted-by":"crossref","first-page":"E644","DOI":"10.1073\/pnas.1423753113","article-title":"Subunit stoichiometry and arrangement in a heteromeric glutamate-gated chloride channel","volume":"113","author":"Degani-Katzav","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.10.005_bb0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S0031182000063812","article-title":"On the distribution of a fluorescent ivermectin probe (4'' 5,7-dimethyl-bodipy proprionylivermectin) in Ascaris membranes","volume":"104","author":"Martin","year":"1992","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2020.10.005_bb0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature10139","article-title":"Principles of activation and permeation in an anion-selective Cys-loop receptor","volume":"474","author":"Hibbs","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.10.005_bb0135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1476-5381.1989.tb14602.x","article-title":"A patch-clamp study of effects of dihydroavermectin on Ascaris muscle","volume":"98","author":"Martin","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006663","article-title":"Effects of glutamate and ivermectin on single glutamate-gated chloride channels of the parasitic nematode H. contortus","volume":"13","author":"Atif","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2020.10.005_bb0145","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.3389\/fimmu.2018.02128","article-title":"Host\u2013parasite interactions promote disease tolerance to intestinal helminth infection","volume":"9","author":"King","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2020.10.005_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.vetpar.2012.12.032","article-title":"Toxocara canis: molecular basis of immune recognition and evasion","volume":"193","author":"Maizels","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0155","doi-asserted-by":"crossref","first-page":"20120","DOI":"10.1073\/pnas.1011983107","article-title":"Ivermectin disrupts the function of the excretory\u2013secretory apparatus in microfilariae of Brugia malayi","volume":"107","author":"Moreno","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.10.005_bb0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.vetpar.2014.02.004","article-title":"Ivermectin-dependent attachment of neutrophils and peripheral blood mononuclear cells to Dirofilaria immitis microfilariae in vitro","volume":"206","author":"Vatta","year":"2014","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0165","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1074\/jbc.M107635200","article-title":"Identification of two novel Drosophila melanogaster histamine-gated chloride channel subunits expressed in the eye","volume":"277","author":"Zheng","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2020.10.005_bb0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10158-007-0050-6","article-title":"Molecular characterisation of a pH-gated chloride channel from Sarcoptes scabiei","volume":"7","author":"Mounsey","year":"2007","journal-title":"Invertebr. Neurosci."},{"key":"10.1016\/j.pt.2020.10.005_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146854","article-title":"Curiouser and curiouser: the macrocyclic lactone, abamectin, is also a potent inhibitor of pyrantel\/tribendimidine nicotinic acetylcholine receptors of gastro-intestinal worms","volume":"11","author":"Abongwa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.10.005_bb0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S0022149X1400039X","article-title":"The Conqueror Worm: recent advances with cholinergic anthelmintics and techniques excite research for better therapeutic drugs","volume":"89","author":"Martin","year":"2015","journal-title":"J. Helminthol."},{"key":"10.1016\/j.pt.2020.10.005_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molbiopara.2013.02.004","article-title":"Derquantel and abamectin: effects and interactions on isolated tissues of Ascaris suum","volume":"188","author":"Puttachary","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0190","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2174\/138920112800399301","article-title":"Treatment of MDR1 mutant dogs with macrocyclic lactones","volume":"13","author":"Geyer","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.pt.2020.10.005_bb0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2885.2012.01424.x","article-title":"Moxidectin has a lower neurotoxic potential but comparable brain penetration in P-glycoprotein-deficient CF-1 mice compared to ivermectin","volume":"36","author":"Janko","year":"2013","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.pt.2020.10.005_bb0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2885.2008.01007.x","article-title":"Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice","volume":"32","author":"Geyer","year":"2009","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.pt.2020.10.005_bb0205","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood\u2013brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.pt.2020.10.005_bb0210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2460\/ajvr.2002.63.479","article-title":"Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States","volume":"63","author":"Mealey","year":"2002","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.pt.2020.10.005_bb0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(02)02955-2","article-title":"MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin","volume":"460","author":"Roulet","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0220","doi-asserted-by":"crossref","first-page":"12556","DOI":"10.1074\/jbc.M011264200","article-title":"Ivermectin, an unconventional agonist of the glycine receptor chloride channel","volume":"276","author":"Shan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2020.10.005_bb0225","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(00)00164-3","article-title":"Activation of rat recombinant alpha(1)beta(2)gamma(2S) GABA(A) receptor by the insecticide ivermectin","volume":"394","author":"Adelsberger","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0230","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/mol.53.2.283","article-title":"Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor","volume":"53","author":"Krause","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(94)90500-2","article-title":"Effect of ivermectin on \u03b3-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones","volume":"259","author":"Kru\u00b0\u0161ek","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0240","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1113\/JP275236","article-title":"Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin","volume":"596","author":"Chen","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.pt.2020.10.005_bb0245","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuron.2007.03.020","article-title":"Ivermectin Interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels","volume":"54","author":"Silberberg","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pt.2020.10.005_bb0250","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jat.3074","article-title":"Assessment of temperature-induced hERG channel blockade variation by drugs","volume":"35","author":"Kauthale","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.pt.2020.10.005_bb0255","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1469-7793.1999.313ae.x","article-title":"Effects of ivermectin and midecamycin on ryanodine receptors and the Ca2+-ATPase in sarcoplasmic reticulum of rabbit and rat skeletal muscle","volume":"514","author":"Ahern","year":"1999","journal-title":"J. Physiol."},{"key":"10.1016\/j.pt.2020.10.005_bb0260","doi-asserted-by":"crossref","first-page":"e1883","DOI":"10.1371\/journal.pntd.0001883","article-title":"Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-\/-) mice and effects on mammalian GABA(A) channel activity","volume":"6","author":"M\u00e9nez","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2020.10.005_bb0265","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1471-4159.2004.02379.x","article-title":"Mutations in the extracellular domains of glutamate-gated chloride channel alpha3 and beta subunits from ivermectin-resistant Cooperia oncophora affect agonist sensitivity","volume":"89","author":"Njue","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pt.2020.10.005_bb0270","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pt.2020.10.005_bb0275","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1087057110390360","article-title":"An AlphaScreen\u00ae-based assay for high-throughput screening for specific inhibitors of nuclear import","volume":"16","author":"Wagstaff","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.pt.2020.10.005_bb0280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.antiviral.2012.06.008","article-title":"Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?","volume":"95","author":"Caly","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.pt.2020.10.005_bb0285","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.pt.2020.10.005_bb0290","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.antiviral.2013.10.004","article-title":"Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan equine encephalitis virus replication","volume":"100","author":"Lundberg","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.pt.2020.10.005_bb0295","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ceb.2019.01.001","article-title":"Inhibitors of nuclear transport","volume":"58","author":"Jans","year":"2019","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.pt.2020.10.005_bb0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.antiviral.2018.09.010","article-title":"Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and in vivo","volume":"159","author":"Lv","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.pt.2020.10.005_bb0305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diagmicrobio.2019.03.012","article-title":"Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system","volume":"95","author":"Ketkar","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.pt.2020.10.005_bb0310","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4269\/ajtmh.20-0271","article-title":"Ivermectin and COVID-19: keeping rigor in times of urgency","volume":"102","author":"Chaccour","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.10.005_bb0315","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002237994","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"Guzzo","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0320","series-title":"The 34th Annual Meeting the Royal College of Physicians of Thailand: \u2018Internal Medicine and One Health\u2019","article-title":"Efficacy and Safety of Ivermectin against Dengue Infection: A Phase III, Randomized, Double-blind, Placebo-controlled Trial","author":"Eakkawit","year":"2018"},{"key":"10.1016\/j.pt.2020.10.005_bb0325","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1038\/cddis.2013.521","article-title":"Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP","volume":"5","author":"Panchal","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.pt.2020.10.005_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02005-16","article-title":"Inhibition of Plasmodium liver infection by ivermectin","volume":"61","author":"Mendes","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.10.005_bb0335","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/acs.jmedchem.0c00033","article-title":"Molecular design and synthesis of ivermectin hybrids targeting hepatic and erythrocytic stages of Plasmodium parasites","volume":"63","author":"Singh","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pt.2020.10.005_bb0340","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/s13071-019-3805-0","article-title":"Inhibition of Plasmodium sporogonic stages by ivermectin and other avermectins","volume":"12","author":"Azevedo","year":"2019","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.pt.2020.10.005_bb0345","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/ncomms2924","article-title":"The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism","volume":"4","author":"Jin","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2020.10.005_bb0350","doi-asserted-by":"crossref","DOI":"10.1038\/srep17288","article-title":"Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease","volume":"5","author":"Jin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2020.10.005_bb0355","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.pt.2020.10.005_bb0360","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/cr.2008.289","article-title":"FXR: a metabolic regulator and cell protector","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.pt.2020.10.005_bb0365","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1016\/j.bmcl.2009.06.062","article-title":"FXR agonist activity of conformationally constrained analogs of GW 4064","volume":"19","author":"Akwabi-Ameyaw","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pt.2020.10.005_bb0370","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.pt.2020.10.005_bb0375","first-page":"317","article-title":"The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug","volume":"8","author":"Juarez","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.pt.2020.10.005_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172784","article-title":"Old wine in new bottles: Drug repurposing in oncology","volume":"866","author":"Antoszczak","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0385","article-title":"Inhibition of TMEM16A Ca","volume":"156","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pt.2020.10.005_bb0390","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjms.2019.11.001","article-title":"Ivermectin augments the in vitro and in vivo efficacy of cisplatin in epithelial ovarian cancer by suppressing Akt\/mTOR signaling","volume":"359","author":"Zhang","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.pt.2020.10.005_bb0395","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.15252\/emmm.201404084","article-title":"The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer","volume":"6","author":"Melotti","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pt.2020.10.005_bb0400","doi-asserted-by":"crossref","DOI":"10.1038\/srep16222","article-title":"Modulation of P2X4\/P2X7\/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death","volume":"5","author":"Draganov","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2020.10.005_bb0405","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1111\/jcmm.15195","article-title":"Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.pt.2020.10.005_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2016.06.015","article-title":"Ivermectin exhibits potent anti-mitotic activity","volume":"226","author":"Ashraf","year":"2016","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0415","first-page":"3397","article-title":"Ivermectin as an inhibitor of cancer stem-like cells","volume":"17","author":"Dominguez-Gomez","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.pt.2020.10.005_bb0420","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.01696-12","article-title":"Anthelmintic avermectins kill Mycobacterium tuberculosis, including multidrug-resistant clinical strains","volume":"57","author":"Lim","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.10.005_bb0425","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/jac\/dku061","article-title":"Comment on: measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent","volume":"69","author":"Muhammed Ameen","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pt.2020.10.005_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003549","article-title":"In-vitro activity of avermectins against Mycobacterium ulcerans","volume":"9","author":"Omansen","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2020.10.005_bb0435","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0165-2427(94)05308-F","article-title":"Influence of ivermectin on cellular and humoral immune responses of lambs","volume":"44","author":"Stankiewicz","year":"1995","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.pt.2020.10.005_bb0440","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.intimp.2008.12.016","article-title":"Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages","volume":"9","author":"Zhang","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0445","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00011-011-0307-8","article-title":"Anti-inflammatory effects of ivermectin in mouse model of allergic asthma","volume":"60","author":"Yan","year":"2011","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.pt.2020.10.005_bb0450","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.ijpara.2014.08.005","article-title":"A dyf-7 haplotype causes sensory neuron defects and is associated with macrocyclic lactone resistance worldwide in the nematode parasite Haemonchus contortus","volume":"44","author":"Urdaneta-Marquez","year":"2014","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0455","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-4017(02)00321-7","article-title":"Amphidial structure of ivermectin-resistant and susceptible laboratory and field strains of Haemonchus contortus","volume":"110","author":"Freeman","year":"2003","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0460","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1038\/s41467-019-12695-4","article-title":"The global diversity of Haemonchus contortus is shaped by human intervention and climate","volume":"10","author":"Sall\u00e9","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2020.10.005_bb0465","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12864-019-5592-6","article-title":"Population genomic and evolutionary modelling analyses reveal a single major QTL for ivermectin drug resistance in the pathogenic nematode, Haemonchus contortus","volume":"20","author":"Doyle","year":"2019","journal-title":"BMC Genom."},{"key":"10.1016\/j.pt.2020.10.005_bb0470","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpddr.2014.07.007","article-title":"Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug\/receptor interactions","volume":"4","author":"Kotze","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.pt.2020.10.005_bb0475","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/bs.apar.2016.02.012","article-title":"Anthelmintic resistance in Haemonchus contortus: history, mechanisms and diagnosis","volume":"93","author":"Kotze","year":"2016","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0480","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00018-003-3336-9","article-title":"The ABC transporter structure and mechanism: perspectives on recent research","volume":"61","author":"Jones","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pt.2020.10.005_bb0485","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FPC.0b013e3283385a1c","article-title":"Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)","volume":"21","author":"Hodges","year":"2011","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.pt.2020.10.005_bb0490","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/sj.bjp.0704620","article-title":"Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins","volume":"135","author":"Hooiveld","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.005_bb0495","series-title":"Annual Meeting of the American Association of Veterinary Parasitologists, abstract no. 72, Honolulu, USA","article-title":"Ivermectin and moxidectin cause constitutive and induced over expression of different P-glycoproteins in resistant Haemonchus contortus","author":"Roulet","year":"2006"},{"key":"10.1016\/j.pt.2020.10.005_bb0500","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijpara.2011.03.015","article-title":"Gene expression changes in a P-glycoprotein (Tci-pgp-9) putatively associated with ivermectin resistance in Teladorsagia circumcincta","volume":"41","author":"Dicker","year":"2011","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2020.10.005_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061635","article-title":"Genetic variants and increased expression of Parascaris equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibility","volume":"8","author":"Janssen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.10.005_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006857","article-title":"Genomic introgression mapping of field-derived multiple-anthelmintic resistance in Teladorsagia circumcincta","volume":"13","author":"Choi","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.pt.2020.10.005_bb0515","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpddr.2016.09.001","article-title":"In silico manuscript analysis of the binding of anthelmintics to Caenorhabditis elegans P-glycoprotein 1","volume":"6","author":"David","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.pt.2020.10.005_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007598","article-title":"The transcription factor NHR-8: A new target to increase ivermectin efficacy in nematodes","volume":"15","author":"M\u00e9nez","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2020.10.005_bb0525","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI130819","article-title":"Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models","volume":"130","author":"Nappi","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pt.2020.10.005_bb0530","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0031182002002251","article-title":"Effects of macrocyclic lactone anthelmintics on feeding and pharyngeal pumping in Trichostrongylus colubriformis in vitro","volume":"125","author":"Sheriff","year":"2002","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2020.10.005_bb0535","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220302907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220302907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:35:41Z","timestamp":1761464141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492220302907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1471492220302907"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2020.10.005","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivermectin: An Anthelmintic, an Insecticide, and Much More","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}